See more : BioVie Inc. (BIVI) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Jingxin Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- E8IGHT (418620.KQ) Income Statement Analysis – Financial Results
- Novavest Real Estate AG (NREN.SW) Income Statement Analysis – Financial Results
- GeckoSystems International Corporation (GOSY) Income Statement Analysis – Financial Results
- Renrui Human Resources Technology Holdings Limited (6919.HK) Income Statement Analysis – Financial Results
- China PengFei Group Limited (3348.HK) Income Statement Analysis – Financial Results
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jingxinpharm.com
About Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs, antihypertensive products, antibiotics, quinolones, gastrointestinal promotions, antidiabetics, antipileptics, antihistamines, H+ pump depressants, antihyper cholesterolemia products, histamine H2 receptor blokades, antihyper cholesterolemirs, antidepressants, cephalosporin products, and biopharma products. It also provides diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, ultrasonic medical displays, and other products. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974 and is headquartered in Xinchang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.00B | 3.78B | 3.34B | 3.26B | 3.65B | 2.94B | 2.22B | 1.88B | 1.42B | 1.24B | 974.43M | 857.58M | 709.73M | 631.02M | 531.47M | 510.31M | 565.22M | 428.87M | 301.88M | 348.22M | 301.51M | 269.95M | 227.05M |
| Cost of Revenue | 1.98B | 1.77B | 1.47B | 1.27B | 1.27B | 1.03B | 911.95M | 864.40M | 698.74M | 659.77M | 574.44M | 559.60M | 522.43M | 442.41M | 367.28M | 361.26M | 439.04M | 310.74M | 204.59M | 261.42M | 220.84M | 208.90M | 185.92M |
| Gross Profit | 2.02B | 2.01B | 1.86B | 1.98B | 2.37B | 1.91B | 1.31B | 1.01B | 716.95M | 575.72M | 399.99M | 297.98M | 187.30M | 188.61M | 164.20M | 149.04M | 126.18M | 118.13M | 97.29M | 86.80M | 80.66M | 61.06M | 41.13M |
| Gross Profit Ratio | 50.57% | 53.27% | 55.85% | 60.92% | 65.08% | 64.85% | 58.90% | 53.91% | 50.64% | 46.60% | 41.05% | 34.75% | 26.39% | 29.89% | 30.89% | 29.21% | 22.32% | 27.54% | 32.23% | 24.93% | 26.75% | 22.62% | 18.12% |
| Research & Development | 400.93M | 367.06M | 329.33M | 259.24M | 254.10M | 242.02M | 164.30M | 110.31M | 74.42M | 53.83M | 42.80M | 37.77M | 15.83M | 14.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 65.92M | 60.10M | 60.23M | 72.34M | 69.34M | 59.06M | 58.54M | 46.82M | 44.29M | 35.73M | 34.21M | 25.71M | 21.14M | 17.14M | 60.23M | 64.88M | 48.26M | 38.73M | 26.34M | 20.77M | 17.82M | 13.71M | 9.08M |
| Selling & Marketing | 621.13M | 791.58M | 760.93M | 965.10M | 1.34B | 1.10B | 679.68M | 501.78M | 364.36M | 311.61M | 204.68M | 144.66M | 63.53M | 91.36M | 79.27M | 65.89M | 60.10M | 49.54M | 33.23M | 29.10M | 25.57M | 17.39M | 16.10M |
| SG&A | 687.04M | 851.68M | 821.17M | 1.04B | 1.41B | 1.16B | 738.22M | 548.60M | 408.66M | 347.34M | 238.89M | 170.37M | 84.67M | 108.51M | 139.50M | 130.77M | 108.36M | 88.26M | 59.57M | 49.87M | 43.39M | 31.11M | 25.18M |
| Other Expenses | 220.31M | 135.66M | 99.76M | 114.69M | 172.12M | -852.17K | 231.92M | 19.42M | 13.00M | 4.80M | 12.73M | 5.00M | 6.95M | 4.51M | 4.47M | 10.14M | 12.07M | 2.89M | -5.91M | 2.61M | 695.31K | 2.66M | 965.78K |
| Operating Expenses | 1.31B | 1.35B | 1.25B | 1.41B | 1.84B | 1.54B | 1.03B | 769.76M | 555.23M | 456.75M | 326.57M | 250.13M | 137.35M | 157.51M | 143.64M | 134.22M | 111.24M | 90.96M | 61.32M | 50.72M | 44.50M | 32.36M | 25.63M |
| Cost & Expenses | 3.28B | 3.12B | 2.72B | 2.68B | 3.11B | 2.57B | 1.94B | 1.63B | 1.25B | 1.12B | 901.00M | 809.73M | 659.77M | 599.92M | 510.92M | 495.48M | 550.28M | 401.70M | 265.91M | 312.14M | 265.35M | 241.25M | 211.55M |
| Interest Income | 60.27M | 65.64M | 48.11M | 20.07M | 7.43M | 1.97M | 4.09M | 6.36M | 12.71M | 7.99M | 8.03M | 7.88M | 2.30M | 2.05M | 6.38M | 8.67M | 3.13M | 1.18M | 732.10K | 1.49M | 382.41K | 260.10K | 1.10M |
| Interest Expense | 9.88M | 6.01M | 3.69M | 6.00M | 10.61M | 5.07M | 74.78K | 8.24M | 7.29M | 5.53M | 13.38M | 16.20M | 22.08M | 18.99M | 23.40M | 38.06M | 22.54M | 11.81M | 5.27M | 4.94M | 4.54M | 3.74M | 4.00M |
| Depreciation & Amortization | 221.47M | 199.95M | 182.53M | 154.42M | 115.31M | 98.23M | 89.80M | 86.55M | 58.87M | 50.59M | 42.45M | 40.99M | 38.99M | 38.22M | 38.79M | 37.37M | 28.14M | 23.04M | 13.44M | 8.51M | 5.66M | 6.14M | 4.60M |
| EBITDA | 945.43M | 962.18M | 893.03M | 927.32M | 726.27M | 523.41M | 336.93M | 340.26M | 269.56M | 190.13M | 132.18M | 103.17M | 97.77M | 71.65M | 70.72M | 65.39M | 52.82M | 52.67M | 43.39M | 48.38M | 42.82M | 31.75M | 19.40M |
| EBITDA Ratio | 23.64% | 24.85% | 25.89% | 27.04% | 20.05% | 17.70% | 27.93% | 19.06% | 18.83% | 15.13% | 13.74% | 11.71% | 13.74% | 11.53% | 12.90% | 13.56% | 9.80% | 12.26% | 14.37% | 13.89% | 14.20% | 11.76% | 8.55% |
| Operating Income | 714.06M | 756.62M | 692.96M | 765.39M | 602.06M | 416.29M | 118.74M | 236.27M | 186.09M | 124.40M | 62.98M | 36.33M | 29.75M | 9.92M | 3.88M | -20.33M | -9.96M | 15.80M | 30.88M | 32.34M | 32.01M | 25.60M | 14.81M |
| Operating Income Ratio | 17.86% | 20.02% | 20.77% | 23.49% | 16.51% | 14.14% | 5.35% | 12.60% | 13.14% | 10.07% | 6.46% | 4.24% | 4.19% | 1.57% | 0.73% | -3.98% | -1.76% | 3.68% | 10.23% | 9.29% | 10.62% | 9.48% | 6.52% |
| Total Other Income/Expenses | -6.02M | -6.30M | 1.48M | -6.41M | 1.35M | 3.00M | 231.92M | 5.49M | 10.61M | 2.52M | 12.73M | 3.55M | 6.95M | -13.85M | 4.47M | 10.08M | 12.07M | -11.53M | -11.57M | -1.18M | 608.41K | 2.40M | 600.66K |
| Income Before Tax | 708.04M | 750.32M | 694.48M | 758.98M | 603.41M | 415.44M | 350.66M | 255.31M | 196.70M | 126.92M | 75.71M | 39.88M | 36.70M | 14.43M | 8.35M | -10.25M | 2.11M | 17.74M | 24.68M | 34.93M | 32.62M | 28.00M | 15.41M |
| Income Before Tax Ratio | 17.71% | 19.85% | 20.82% | 23.30% | 16.55% | 14.11% | 15.80% | 13.61% | 13.89% | 10.27% | 7.77% | 4.65% | 5.17% | 2.29% | 1.57% | -2.01% | 0.37% | 4.14% | 8.18% | 10.03% | 10.82% | 10.37% | 6.79% |
| Income Tax Expense | 84.62M | 82.49M | 79.78M | 105.65M | 81.47M | 43.95M | 83.64M | 38.58M | 30.08M | 19.83M | 11.36M | 8.20M | 7.58M | 1.47M | 4.38M | 8.00M | 658.24K | 7.27M | 6.23M | 9.14M | 7.21M | 5.72M | 5.44M |
| Net Income | 618.90M | 662.25M | 612.54M | 653.07M | 520.40M | 370.04M | 264.38M | 211.95M | 165.21M | 107.08M | 64.35M | 31.68M | 29.12M | 12.90M | 3.75M | -17.73M | 1.50M | 10.49M | 18.45M | 25.79M | 25.40M | 22.28M | 9.97M |
| Net Income Ratio | 15.48% | 17.52% | 18.36% | 20.04% | 14.27% | 12.57% | 11.91% | 11.30% | 11.67% | 8.67% | 6.60% | 3.69% | 4.10% | 2.04% | 0.71% | -3.47% | 0.27% | 2.45% | 6.11% | 7.41% | 8.43% | 8.25% | 4.39% |
| EPS | 0.72 | 0.77 | 0.75 | 0.83 | 0.64 | 0.43 | 0.33 | 0.26 | 0.24 | 0.17 | 0.11 | 0.05 | 0.06 | 0.03 | 0.01 | -0.04 | 0.00 | 0.03 | 0.06 | 0.06 | 0.08 | 0.07 | 0.05 |
| EPS Diluted | 0.72 | 0.77 | 0.75 | 0.83 | 0.64 | 0.43 | 0.33 | 0.26 | 0.24 | 0.17 | 0.11 | 0.05 | 0.06 | 0.03 | 0.01 | -0.04 | 0.00 | 0.03 | 0.06 | 0.06 | 0.08 | 0.07 | 0.05 |
| Weighted Avg Shares Out | 859.58M | 860.07M | 816.72M | 791.19M | 814.43M | 867.20M | 805.21M | 765.82M | 686.99M | 647.34M | 605.35M | 608.04M | 506.43M | 487.39M | 486.83M | 486.30M | 481.22M | 488.04M | 481.22M | 481.22M | 905.32M | 905.32M | 905.32M |
| Weighted Avg Shares Out (Dil) | 859.58M | 860.07M | 816.72M | 791.19M | 814.43M | 867.20M | 805.21M | 765.82M | 687.08M | 647.34M | 605.63M | 608.24M | 506.43M | 487.39M | 486.83M | 486.30M | 481.22M | 488.04M | 481.22M | 481.22M | 905.32M | 905.32M | 905.32M |
Source: https://incomestatements.info
Category: Stock Reports